These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7540121)

  • 21. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
    Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mediators involved in the nephrotoxicity of cyclosporin A].
    Simon N; Barré J; Jolliet P; Urien S; Tillement JP
    Therapie; 1997; 52(4):329-33. PubMed ID: 9437887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcineurin inhibitor nephrotoxicity.
    Naesens M; Kuypers DR; Sarwal M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):481-508. PubMed ID: 19218475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
    Andoh TF; Burdmann EA; Fransechini N; Houghton DC; Bennett WM
    Kidney Int; 1996 Oct; 50(4):1110-7. PubMed ID: 8887267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic features of cyclosporin nephrotoxicity.
    D'Agati VD
    Contrib Nephrol; 1995; 114():84-110. PubMed ID: 7587203
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem].
    Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B
    Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339
    [No Abstract]   [Full Text] [Related]  

  • 32. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
    J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients.
    Kneteman NM; Lakey JR; Wagner T; Finegood D
    Transplant Proc; 1995 Dec; 27(6):3213. PubMed ID: 8539919
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation.
    Paramesh AS; Grosskreutz C; Florman SS; Gondolesi GE; Sharma S; Kaufman SS; Fishbein TM
    Transplantation; 2004 Jan; 77(1):129-31. PubMed ID: 14724447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and chronic nephrotoxicity associated with immunosuppressive drugs.
    Whiting PH
    Curr Opin Nephrol Hypertens; 1994 Mar; 3(2):174-81. PubMed ID: 7531104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic cyclosporine nephrotoxicity.
    Andoh TF; Bennett WM
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):265-70. PubMed ID: 9617556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with cyclosporine in endogenous uveitis posterior.
    Hesselink DA; Baarsma GS; Kuijpers RW; van Hagen PM
    Transplant Proc; 2004 Mar; 36(2 Suppl):372S-377S. PubMed ID: 15041371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.
    Andoh TF; Lindsley J; Franceschini N; Bennett WM
    Transplantation; 1996 Aug; 62(3):311-6. PubMed ID: 8779675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.